Washington-based AI-powered synthetic biology company AbSci and the California Institute of Technology (Caltech) have entered a collaboration, backed by a grant from the Bill & Melinda Gates Foundation (amount undisclosed), to discover an affordable HIV vaccine using advanced technologies including GenAI, structural biology, and protein design.
The duo will leverage the synergies arising from the partnership to develop an affordable and accessible vaccine for human immunodeficiency virus (HIV) that can potentially treat and prevent infection from all strains of the virus.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.